Pifeltro
FDA Accepts sNDAs for Pifeltro and Delstrigo
The FDA agreed to review a supplemental New Drug Applications (sNDAs) for Merck’s Pifeltro and Delstrigo for ...
JANUARY 23, 2019
FDA Approves Delstrigo and Pifeltro for HIV Treatment
The FDA approved Merck’s two doravirine-based HIV-1 medicines: Delstrigo, a once-daily fixed-dose combination ...
AUGUST 30, 2018
Load more